New approaches to genetic manipulation of mice: tissue-specific expression of ACE.

No abstract is available for this paper.

• Publication year

  2003

• Venue

  AJP - Renal Physiology

• Publication date

  2003-04-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1152/AJPRENAL.00308.2002PMID 12620918
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• The immunocytochemical detection of angiotensin-converting enzyme in alveolar macrophages from patients with sarcoidosis

  2007cited by this paper
• Mice Lacking Endothelial Angiotensin-Converting Enzyme Have a Normal Blood Pressure

  2002cited by this paper
• Impaired urine concentration and absence of tissue ACE: involvement of medullary transport proteins.

  2002cited by this paper
• Genetic Evidence That Lethality in Angiotensinogen-deficient Mice Is Due to Loss of Systemic but Not Renal Angiotensinogen*

  2001cited by this paper
• Conditional control of gene expression in the mouse

  2001cited by this paper
• Theodore Cooper Lecture: Tissue angiotensin and pathobiology of vascular disease: a unifying hypothesis.

  2001cited by this paper
• Angiotensin-converting enzyme inhibition induces apoptosis in erythroid precursors and affects insulin-like growth factor-1 in posttransplantation erythrocytosis.

  2001cited by this paper
• Lack of angiotensin II-facilitated erythropoiesis causes anemia in angiotensin-converting enzyme-deficient mice.

  2000cited by this paper
• Dual renin gene targeting by Cre-mediated interchromosomal recombination.

  2000cited by this paper
• Renin-dependent Cardiovascular Functions and Renin-independent Blood-Brain Barrier Functions Revealed by Renin-deficient Mice*

  2000cited by this paper
• Association between activation of the renin-angiotensin system and secondary erythrocytosis in patients with chronic obstructive pulmonary disease.

  1999cited by this paper
• The renal lesions that develop in neonatal mice during angiotensin inhibition mimic obstructive nephropathy.

  1999cited by this paper
• Overt nephrogenic diabetes insipidus in mice lacking the CLC-K1 chloride channel

  1999cited by this paper
• The role of ACE inhibitors and angiotensin II receptor blockers in the response to epoetin.

  1999cited by this paper
• Reduced growth, abnormal kidney structure, and type 2 (AT2) angiotensin receptor-mediated blood pressure regulation in mice lacking both AT1A and AT1B receptors for angiotensin II.

  1998cited by this paper
• Murine double nullizygotes of the angiotensin type 1A and 1B receptor genes duplicate severe abnormal phenotypes of angiotensinogen nullizygotes.

  1998cited by this paper
• Selective restoration of male fertility in mice lacking angiotensin-converting enzymes by sperm-specific expression of the testicular isozyme.

  1998cited by this paper
• Angiotensin induces the urinary peristaltic machinery during the perinatal period.

  1998cited by this paper
• Jak2 deficiency defines an essential developmental checkpoint in definitive hematopoiesis.

  1998cited by this paper
• Vascular angiotensin-converting enzyme expression regulates local angiotensin II.

  1997cited by this paper
• Angiotensin-converting enzyme gene mutations, blood pressures, and cardiovascular homeostasis.

  1997cited by this paper
• The critical role of tissue angiotensin-converting enzyme as revealed by gene targeting in mice.

  1997cited by this paper
• Targeting deletion of angiotensin type 1B receptor gene in the mouse.

  1997cited by this paper
• Renin-1 Is Essential for Normal Renal Juxtaglomerular Cell Granulation and Macula Densa Morphology*

  1997cited by this paper
• The Kidney Androgen-regulated Protein Promoter Confers Renal Proximal Tubule Cell-specific and Highly Androgen-responsive Expression on the Human Angiotensinogen Gene in Transgenic Mice*

  1997cited by this paper
• Mice lacking angiotensin-converting enzyme have low blood pressure, renal pathology, and reduced male fertility.

  1996cited by this paper
• Thrombopoietin rescues in vitro erythroid colony formation from mouse embryos lacking the erythropoietin receptor.

  1996cited by this paper
• Targeted inactivation of the Ren-2 gene in mice.

  1996cited by this paper
• Differential effects of an erythropoietin receptor gene disruption on primitive and definitive erythropoiesis.

  1996cited by this paper
• Estrogen regulates the stage-specific expression of kidney androgen-regulated protein in rat uterus during reproductive cycle and pregnancy.

  1996cited by this paper
• Chimeric mice carrying 'regional' targeted deletion of the angiotensin type 1A receptor gene. Evidence against the role for local angiotensin in the in vivo feedback regulation of renin synthesis in juxtaglomerular cells.

  1996cited by this paper
• Increased accumulation of tissue ACE in human atherosclerotic coronary artery disease.

  1996cited by this paper
• Genetic control of blood pressure and the angiotensinogen locus.

  1995cited by this paper
• Direct stimulation of Jak/STAT pathway by the angiotensin II AT1 receptor

  1995cited by this paper
• Effects on blood pressure and exploratory behaviour of mice lacking angiotensin II type-2 receptor

  1995cited by this paper
• Behavioural and cardiovascular effects of disrupting the angiotensin II type-2 receptor gene in mice

  1995cited by this paper
• Male–female differences in fertility and blood pressure in ACE-deficient mice

  1995cited by this paper
• Generation of committed erythroid BFU-E and CFU-E progenitors does not require erythropoietin or the erythropoietin receptor.

  1995cited by this paper
• Gene targeting in mice reveals a requirement for angiotensin in the development and maintenance of kidney morphology and growth factor regulation.

  1995cited by this paper
• Angiotensin II Type 1a Receptor-deficient Mice with Hypotension and Hyperreninemia (*)

  1995cited by this paper
• Regulation of blood pressure by the type 1A angiotensin II receptor gene.

  1995cited by this paper
• Behavioural and cardiovascular effects of disrupting the angiotensin II type-2 receptor in mice.

  1995cited by this paper
• Targeted gene replacement.

  1994cited by this paper
• Angiotensinogen-deficient mice with hypotension.

  1994cited by this paper
• Gene expression and tissue localization of the two isoforms of angiotensin I converting enzyme.

  1993cited by this paper
• Proteolytic release of human angiotensin-converting enzyme. Localization of the cleavage site.

  1993cited by this paper
• The two homologous domains of human angiotensin I-converting enzyme are both catalytically active.

  1991cited by this paper
• Transcription of testicular angiotensin-converting enzyme (ACE) is initiated within the 12th intron of the somatic ACE gene

  1990cited by this paper
• Mouse angiotensin-converting enzyme is a protein composed of two homologous domains.

  1989cited by this paper
• Molecular cloning of human testicular angiotensin-converting enzyme: the testis isozyme is identical to the C-terminal half of endothelial angiotensin-converting enzyme.

  1989cited by this paper
• The testicular transcript of the angiotensin I‐converting enzyme encodes for the ancestral, non‐duplicated form of the enzyme

  1989cited by this paper
• Structure of testicular angiotensin-converting enzyme. A segmental mosaic isozyme.

  1989cited by this paper
• Two putative active centers in human angiotensin I-converting enzyme revealed by molecular cloning.

  1988cited by this paper
• Mouse kidney androgen-regulated protein messenger ribonucleic acid is expressed in the proximal convoluted tubules.

  1987cited by this paper
• An albumin enhancer located 10 kb upstream functions along with its promoter to direct efficient, liver-specific expression in transgenic mice.

  1987cited by this paper
• Angiotensin converting enzyme in rat brain visualized by quantitative in vitro autoradiography.

  1987cited by this paper
• Concentrations of angiotensin-converting enzyme in tissues of the rat.

  1971cited by this paper
• Nephrology Dialysis Transplantation the Impact of Withdrawing Ace Inhibitors on Erythropoietin Responsiveness and Left Ventricular Hypertrophy in Haemodialysis Patients

  year unknowncited by this paper

• Renal angiotensin I-converting enzyme-deficient mice are protected against aristolochic acid nephropathy

  2022cites this paper
• Role of the angiotensin-converting enzyme in the G-CSF-induced mobilization of progenitor cells

  2018cites this paper
• Local Renin-Angiotensin System at Liver and Crosstalk with Hepatic Diseases

  2017cites this paper
• Angiotensin-Converting Enzyme in Smooth Muscle Cells Promotes Atherosclerosis—Brief Report

  2016cites this paper
• Angiotensin-converting enzymes and drug discovery in cardiovascular diseases.

  2010cites this paper
• GENETIC MODELS PROVIDE UNIQUE INSIGHT INTO ANGIOTENSIN AND BRADYKININ PEPTIDES IN THE EXTRAVASCULAR COMPARTMENT OF THE HEART IN VIVO

  2009cites this paper
• Expression of Angiotensin-converting Enzyme Changes Major Histocompatibility Complex Class I Peptide Presentation by Modifying C Termini of Peptide Precursors*

  2008cites this paper
• Tumorigenesis and Neoplastic Progression Mice with Enhanced Macrophage Angiotensin-Converting Enzyme Are Resistant to Melanoma

  2007cites this paper
• Physiology of local renin-angiotensin systems.

  2006cites this paper
• ROLE OF MECHANICAL VERSUS HUMORAL EFFECTS OF ANGIOTENSIN II ON VASCULAR REMODELING

  2006cites this paper
• ROLE OF MECHANICAL VERSUS HUMORAL EFFECTS OF ANGIOTENSIN II ON VASCULAR REMODELING

  2006cites this paper
• Establishing the role of angiotensin-converting enzyme in renal function and blood pressure control through the analysis of genetically modified mice.

  2005cites this paper
• Differential Effects of Angiotensin II Type-1 Receptor Antisense Oligonucleotides on Renal Function in Spontaneously Hypertensive Rats

  2005cites this paper
• Shedding of the Germinal Angiotensin I-Converting Enzyme (gACE) Involves a Serine Protease and Is Activated by Epididymal Fluid1

  2005cites this paper
• Blood Pressure Regulation by Vasoactive Peptide Genes: Transgenic And Knockout Animal Models

  2005cites this paper
• Mechanisms of paracrine and endocrine actions of Angiotensin II

  2004cites this paper
• Neutral endopeptidase and angiotensin‐converting enzyme – key enzymes terminating the action of neuroendocrine mediators

  2004cites this paper
• The use of knockout mouse technology to achieve tissue selective expression of angiotensin converting enzyme.

  2004cites this paper
• Gene expression profiles in rat intestine identify pathways for 1,25-dihydroxyvitamin D3 stimulated calcium absorption and clarify its immunomodulatory properties

  2004cites this paper
• Role of the N-terminal Catalytic Domain of Angiotensin-converting Enzyme Investigated by Targeted Inactivation in Mice*

  2004cites this paper
• Role of bradykinin in angiotensin-converting enzyme knockout mice.

  2003cites this paper
• Untraditional methods for targeting the kidney in transgenic mice.

  2003cites this paper
• Gene-engineered models for genetic manipulation and functional analysis of the cardiovascular system in mice.

  2003cites this paper